IgG Kappa Multiple Myeloma: What Does Your Subtype Mean?

When your doctor says you have “IgG Kappa” multiple myeloma, they are simply describing the specific type of protein your cancer cells are producing. Multiple myeloma is a cancer of plasma cells, which are the cells in your immune system that normally make antibodies to fight infections ^[1]. Antibodies are made up of two parts: larger pieces called heavy chains (such as “IgG” or “IgA”) and smaller pieces called light chains (such as “Kappa” or “Lambda”) ^[1]. Therefore, “IgG Kappa” means your myeloma cells are overproducing an antibody made of an IgG heavy chain and a Kappa light chain ^[2][3]. This is not a separate disease from multiple myeloma, but rather a “nametag” for your specific cancer ^[4]. In fact, IgG Kappa is the most common subtype of multiple myeloma ^[5].

Breaking Down the Letters: Heavy and Light Chains

To understand these terms, it helps to know how antibodies are built in the body. Every antibody has a “Y” shape created by combining heavy and light chains ^[1].

• Heavy Chains (The “IgG” or “IgA” part): The heavy chain determines the overall “class” or family of the antibody ^[6]. The most common classes involved in multiple myeloma are IgG and IgA, though others like IgM, IgD, or IgE exist ^[7][6].
• Light Chains (The “Kappa” or “Lambda” part): Attached to the heavy chains are smaller pieces called light chains ^[8]. There are only two types of light chains in humans: Kappa and Lambda ^[1][8].

When plasma cells become cancerous in multiple myeloma, they multiply out of control and produce identical copies of one specific antibody ^[9]. If a patient’s myeloma cells produce an IgA heavy chain with a Lambda light chain, their subtype is called “IgA Lambda.” If they produce an IgG heavy chain with a Kappa light chain, they have “IgG Kappa” myeloma ^[2][3].

Why Doctors Track Your Subtype

Your specific subtype is important for identification, but it generally does not change your overall treatment plan or prognosis as much as other factors, such as your genetics or the stage of the disease ^[10][11]. Instead, doctors use these specific letters as a tool to track your cancer over time ^[11].

• The M-Protein and M-Spike: The abnormal, identical antibody overproduced by myeloma cells is called a monoclonal protein, or M-protein ^[12][4]. On your lab results, the amount of this protein is very commonly referred to as your M-spike (usually measured in g/dL).
• Monitoring Disease: By continually measuring the exact amount of your specific M-protein (your M-spike) in your blood or urine, doctors can monitor how much cancer is present in your body ^[13]. It is important to remember that everyone’s baseline M-spike level is different, so try not to compare your absolute numbers with other patients.
• Tracking Treatment Response: If your M-spike levels go down after you start treatment, it means the therapy is effectively killing the myeloma cells ^[13][14].

Tests You Might See on Your Patient Portal

To figure out your subtype and monitor your M-protein levels, your care team will use specific tests. On your portal, the word “Serum” simply means the clear, liquid part of the blood.

• SPEP and UPEP: Serum Protein Electrophoresis (SPEP) and Urine Protein Electrophoresis (UPEP) are tests used to find and measure the quantity of the M-protein (your M-spike) ^[12][15]. UPEP involves a 24-hour urine collection to catch proteins that have filtered through the kidneys.
• IFE: Immunofixation (IFE) is a particularly sensitive test used to identify exactly which heavy and light chains the M-protein is made of ^[12][16]. While SPEP measures the size of the M-spike, IFE is the test that actually confirms the “IgG” and “Kappa” labels ^[15][16].
• Serum Free Light Chain (sFLC) Assay: This test measures the amount of light chains (Kappa and Lambda) that are floating freely in your blood, unattached to heavy chains ^[17]. A healthy person will have a normal balance between free Kappa and free Lambda, but multiple myeloma causes an abnormal ratio ^[9]. If you have IgG Kappa myeloma, your Kappa levels will be the ones that are elevated, pushing the ratio out of balance ^[3]. Tracking this ratio helps doctors monitor your response to therapy ^[17].